Browse by Phase
Phase 1 Clinical Trials
Phase 1 trials test a new drug or treatment in a small group (20–80 people) for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects.
Total Trials
624
Recruiting Now
624
Top Conditions in Phase 1
NCT06647979 Phase 1
Recruiting
Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopat...
Condition
Sickle Cell Disease
Enrollment
10 pts
Location
United States
Sponsor
Daniel Bauer
NCT07358546 Phase 1
Recruiting
A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
Condition
Non-alcoholic Fatty Liver Disease
Enrollment
32 pts
Location
United States
Sponsor
GlaxoSmithKline
NCT06451497 Phase 1
Recruiting
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Fo...
Condition
Non Small Cell Lung Cancer
Enrollment
100 pts
Location
United States
Sponsor
Zumutor Biologics Inc.
NCT06949410 Phase 1
Recruiting
HER2 Vaccine for Locally Advanced Breast Cancer
Condition
Breast Cancer
Enrollment
36 pts
Location
United States
Sponsor
Pravin T.P Kaumaya
NCT06084962 Phase 1
Recruiting
A Study of DeepTag-GPRC5D Targeted CAR-T Cells Therapy for Refractory/Relapsed M...
Condition
Relapse/Refractory Multiple Myeloma
Enrollment
40 pts
Location
China
Sponsor
He Huang
NCT07107750 Phase 1
Recruiting
Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab...
Condition
Metastatic Biliary Tract Cancer
Enrollment
48 pts
Location
United States
Sponsor
Washington University School o
NCT06739291 Phase 1
Recruiting
A Study of SIGX1094R in Patients With Advanced Solid Tumors
Condition
Advanced Solid Tumors
Enrollment
102 pts
Location
China
Sponsor
Signet Therapeutics
NCT06616623 Phase 1
Recruiting
Vismodegib and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Sma...
Condition
Metastatic Lung Non-Small Cell Carcinoma
Enrollment
24 pts
Location
United States
Sponsor
Dwight Owen
NCT06575296 Phase 1
Recruiting
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem C...
Condition
Acute Leukemia
Enrollment
27 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT02359825 Phase 1
Recruiting
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed A...
Condition
Peripheral Nerve Injury
Enrollment
18 pts
Location
United States
Sponsor
Vanderbilt University Medical
NCT06768489 Phase 1
Recruiting
A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalido...
Condition
Multiple Myeloma
Enrollment
140 pts
Location
Australia, Israel, Netherlands
Sponsor
Janssen Research & Development
NCT07495813 Phase 1
Recruiting
A Study to See How RO7763505 Works and How Safe it is When Given to Healthy Peop...
Condition
Stable Coronary Artery Disease
Enrollment
196 pts
Location
Netherlands
Sponsor
Hoffmann-La Roche
NCT07493044 Phase 1
Recruiting
An Open-Label, Phase I Clinical Trial of Super CAR-T With GPC3-Positive Advanced...
Condition
Advanced Hepatocellular Carcinoma (HCC)
Enrollment
15 pts
Location
China
Sponsor
Guangzhou FineImmune Biotechno
NCT07110532 Phase 1
Recruiting
pH1N1 Blinded Challenge Study
Condition
Influenza
Enrollment
180 pts
Location
United States
Sponsor
National Institute of Allergy
NCT05869955 Phase 1
Recruiting
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Seve...
Condition
Systemic Lupus Erythematosus
Enrollment
270 pts
Location
United States, Belgium, France
Sponsor
Juno Therapeutics, Inc., a Bri
NCT04780568 Phase 1
Recruiting
Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic...
Condition
Metastatic Lung Non-Small Cell Carcinoma
Enrollment
24 pts
Location
United States
Sponsor
Ohio State University Comprehe
NCT07260591 Phase 1
Recruiting
VSV-02 Compassionate Use in Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
6 pts
Location
China
Sponsor
The First Affiliated Hospital
NCT06787144 Phase 1
Recruiting
ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mu...
Condition
CML (Chronic Myelogenous Leukemia)
Enrollment
21 pts
Location
Japan
Sponsor
Enliven Therapeutics
NCT06042725 Phase 1
Recruiting
MC210808 Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven-Rd),...
Condition
Multiple Myeloma
Enrollment
100 pts
Location
United States
Sponsor
Mayo Clinic
NCT06450210 Phase 1
Recruiting
Safety for Home Administration of Microdose Psilocybin Use
Condition
Psychedelic Experiences
Enrollment
20 pts
Location
United States
Sponsor
Johns Hopkins University
NCT06992713 Phase 1
Recruiting
A Clinical Study Evaluating H1710 for Injection in Participants With Advanced So...
Condition
Advanced Solid Tumor
Enrollment
36 pts
Location
China
Sponsor
Shenzhen Hepalink Pharmaceutic
NCT05701709 Phase 1
Recruiting
Phase I Study of SHR-A2102 in Patients With Advanced Solid Tumors
Condition
Advanced Solid Tumors
Enrollment
395 pts
Location
China
Sponsor
Shanghai Hengrui Pharmaceutica
NCT04715191 Phase 1
Recruiting
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Exp...
Condition
Liver Cancer
Enrollment
24 pts
Location
United States
Sponsor
Baylor College of Medicine
NCT06559618 Phase 1
Recruiting
Bacteriophage Therapy in Spinal Cord Injury Patients With Bacteriuria
Condition
Bacteriuria
Enrollment
30 pts
Location
United States
Sponsor
Barbara Wells Trautner
NCT07160335 Phase 1
Recruiting
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immuno...
Condition
Non-small Cell Lung Cancer
Enrollment
174 pts
Location
United States, China, Georgia
Sponsor
Shanghai Henlius Biotech